logo

For the Inventor, By the Inventor

Berkeley, CA, United States of America

Pablo D T Valenzuela

This inventor holds 6 USPTO granted patents. Top assignee: Chiron Corporation. Active years: 2001-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pablo D T Valenzuela. Retrieved from https://idiyas.com/inventor/pablo-d-t-valenzuela

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 2.3

ph-index = 5

Forward Citations = 135(Granted Patents)


Location History:

  • Santiago, CL (2003)
  • Berkeley, CA (US) (2001 - 2006)

Company Filing History:

goldMedal6 out of 672 
 
Chiron Corporation
 patents

Years Active: 2001-2006

Loading Chart...
6 patents (USPTO):Explore Patents
1. 7056658 - Multiple epitope fusion protein (2006-06-06),
2. 6844168 - Compositions comprising polynucleotides encoding human fibroblast growth factor receptor and uses thereof (2005-01-18),
3. 6642029 - Hybrid DNA synthesis of mature insulin-like growth factors (2003-11-04),
4. 6514731 - Methods for the preparation of hepatitis C virus multiple copy epitope fusion antigens (2003-02-04),
5. 6428792 - Hepatitis C virus multiple copy epitope fusion antigens (2002-08-06),
6. 6255454 - Expression and use of human fibroblast growth factor receptor (2001-07-03),

Title: The Innovations of Pablo D T Valenzuela

Introduction

Pablo D T Valenzuela is a prominent inventor based in Berkeley, CA. He has made significant contributions to the field of biotechnology, holding a total of 6 patents. His work primarily focuses on the development of innovative proteins and receptors that have important applications in medical research and treatment.

Latest Patents

Valenzuela's latest patents include groundbreaking inventions such as multiple epitope fusion proteins. These proteins are designed for use in immunoassays and are characterized by a specific structural formula that allows for the incorporation of various amino acid sequences. Another notable patent involves the cloning and expression of a new receptor for fibroblast growth factor. This recombinant receptor is instrumental in inhibiting FGF activity and is useful for screening compounds that exhibit similar binding activity to FGF.

Career Highlights

Throughout his career, Valenzuela has been associated with Chiron Corporation, where he has contributed to various research initiatives. His innovative work has not only advanced scientific understanding but has also paved the way for new therapeutic approaches in medicine.

Collaborations

Valenzuela has collaborated with esteemed colleagues such as David Y Chien and Michael C Keifer. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.

Conclusion

Pablo D T Valenzuela's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to influence medical research and innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…